Novavax To Begin New Coronavirus Vaccine's Clinical Trials; It Will Send COVID-19's Spike Proteins Into The Body To Stimulate Immune Response A new coronavirus vaccine will send COVID-19's spike proteins into the body to activate the immune response. Novavax is beginning its clinical trials. by Giuliano J. de Leon